We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proe... Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body's primary defense against cancer. Show more
This biopharma is developing novel cancer treatments for patients suffering from recurring and metastatic cancer. Shares were trading up after the firm announced that a Certificate of Grant for...
In the biotech space, sometimes all it takes for a stock to move is a simple indication that things are going well during a specific trial or if there is any mention of the FDA To read the full...
Whenever a company gets a nod of approval from a regulatory agency, it is usually a major feat achieved after months of hard work by the company. Just today, a biopharmaceutical To read the full...
July 28, 2020 -- InvestorsHub NewsWire -- via NextBigTicker -- Alternet Systems, Inc. (USOTC: ALYI) is rated a BUY today by AmericanBulls (americanbulls.com/ALYI). Yesterday...
Under the Radar Biotechs To Research Now May 30, 2019 -- InvestorsHub NewsWire -- via microcapspeculators.com -- While Amgen (AMGN) offering to buy a drug discovery platform...
Biotech Stock Closing in on Human Trials May 17, 2019 -- InvestorsHub NewsWire -- Microcap Speculators -- Growth based biotech stocks are one of the few sectors that aren’t...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0003 | 0.0004 | 0.0002 | 2275111 | 0.00029093 | CS |
4 | 0 | 0 | 0.0003 | 0.0004 | 0.0002 | 4094413 | 0.00033034 | CS |
12 | -0.000175 | -36.8421052632 | 0.000475 | 0.0005 | 0.0002 | 6539572 | 0.00035242 | CS |
26 | -0.0009 | -75 | 0.0012 | 0.0037 | 0.0002 | 18942249 | 0.00101832 | CS |
52 | -0.0093 | -96.875 | 0.0096 | 0.02 | 0.0002 | 11704803 | 0.00143075 | CS |
156 | -21.9997 | -99.9986363636 | 22 | 45 | 0.0002 | 19997091 | 1.12453358 | CS |
260 | -299.9997 | -99.9999 | 300 | 1750 | 0.0002 | 14393727 | 2.11338016 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions